FDA Brief

Warning letters Drugs

FDA warning letter to

Excelvision Fareva

Issued May 7, 2025Posted May 13, 2025Center for Drug Evaluation and Research (CDER)

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Excelvision Fareva's FDA history

  1. Excelvision - Fareva

    FDA warned Excelvision-Fareva after a 2026 inspection found inadequate contamination investigations and aseptic failures for sterile drugs.

    High risk

Full company page